The present chairman of Singapore's Biomedical Research Council (BMRC) Prof Sir George Radda has changed the way universities in Singapore approach the research paradigm. His pioneering efforts have elevated Singapore's research potential... Read more
Driven by the demand for affordable and simple diagnostics, VolitionRx has been focusing on diagnostic tests for cancer that... Read more
Steering Bionomics' focus towards large markets where there is a defined clinical need for new treatments, Dr Rathjen helped... Read more
About 500 bioscience companies comprising pharmaceutical, biotechnology and medical technology companies listed on different stock exchanges... Read more
Driving in the niche industry of sleep disorders, ResMed was aggressive in strengthening its portfolio through acquisitions and product... Read more
With the rising cost of fuel and the depleting reserves, the world is pinning its hopes on viable options for biofuels. While many companies... Read more
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market. Without missing... Read more
The top 10 pharmaceutical products being sold in the Japanese market, by both local and foreign players, contribute to about 10 percent... Read more
Australia, with its 2011 revenue of $13 billion, occupies the second largest share of the Asia Pacific pharma market followed by China.... Read more
In 2011, China maintained its top position in the Asia Pacific's region for pharmaceutical industry, with the largest share of the market.... Read more
India, which has the second largest population in the world and is among the top three nations in terms of patient pool, secured revenues... Read more
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 2011, riding on various... Read more
Survey Box